Skip to main
GPAT
GPAT logo

GPAT Market Capitalization Overview

Market Cap: $380.58M as of Jun 13, 2025

$380.58M
Past Month+$3.60M (0.95%)
As of Jun 13, 2025, GPAT has a market capitalization of $380.58M. Over the past 30 days, its market cap has increased by 0.77%, while in the last 12 months, it has increased by 4.44%.

Market capitalization represents the total value of GP-Act III Acquisition Corp as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

GPAT Market Cap Formula = Stock Price * Shares Outstanding

The market cap of GPAT helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

GPAT Market Cap History

DateMarket CapChange
Jun 2, 2025$376.63M+0.77%
May 1, 2025$373.75M+0.90%
Apr 1, 2025$370.41M+0.55%
Mar 3, 2025$368.36M+0.10%
Feb 3, 2025$368.00M+0.89%
Jan 2, 2025$364.77M+0.12%

GPAT End of Year Market Cap History

DateMarket CapChange
2025$380.58M+4.44%
2024$364.41M

FAQs About GP-Act III Acquisition Corp (GPAT) Market Cap

As of Jun 13, 2025, the market capitalization of GPAT is $380.58M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, GP-Act III Acquisition Corp’s market capitalization has increased by 0.9500%, changing from $376.99M to $380.58M as of Jun 13, 2025.

In the last 3 months, GP-Act III Acquisition Corp’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, GP-Act III Acquisition Corp’s market capitalization increased from – in January to $364.41M in December, reflecting a — change.

GP-Act III Acquisition Corp (GPAT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.